Gleamer

Paris, France Founded: 2017 • Age: 9 yrs Acquired By RadNet
An AI platform for radiography image analysis is provided.

About Gleamer

Gleamer is a company based in Paris (France) founded in 2017 was acquired by RadNet in March 2026.. Gleamer has raised $40.01 million across 4 funding rounds from investors including RadNet, EIT Health and Bpifrance. Gleamer has completed 1 acquisition, including Pixyl. Gleamer offers products and services including BoneView, ChestView, BoneMetrics, BoneAge, and BreastView. Gleamer operates in a competitive market with competitors including Perspectum, Qure.ai, IXICO, Zebra Medical Vision and Deeptek, among others.

  • Headquarter Paris, France
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Health Technology & Digital Health
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $40.01 M (USD)

    in 4 rounds

  • Latest Funding Round
    $29.55 M (USD), Series B

    Jun 28, 2023

  • Investors
    RadNet

    & 11 more

  • Employee Count
    Employee Count
  • Investments & Acquisitions
  • Acquired by
    RadNet

    (Mar 02, 2026)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Gleamer

Gleamer offers a comprehensive portfolio of products and services, including BoneView, ChestView, BoneMetrics, BoneAge, and BreastView. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Detects bone trauma in X-rays for improved accuracy.

Enhances detection of urgent chest findings and cancers.

Automates musculoskeletal measurements to save time.

Determines bone age beyond traditional methods accurately.

Aids in early detection of breast cancer through precision AI.

People of Gleamer
Headcount 50-200
Employee Profiles 38
Board Members and Advisors 3
Employee Profiles
People
Antoine Tournier
Head of QARA
People
Jeanne Ventre
Head Of Clinical Affairs
People
Manon Toumelin
Head Of AI Clinical Specialists
People
Nicolas Jirikoff
Chief Business Officer

Unlock access to complete

Board Members and Advisors
people
Nicolas Theumann
Medical Board Member
people
Jean-Denis Laredo
Medical Board Member
people
Gabriel Krestin
Medical Board Member

Unlock access to complete

Funding Insights of Gleamer

Gleamer has successfully raised a total of $40.01M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $29.55 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Series B — $29.5M
  • First Round

    (24 Sep 2018)

  • Investors Count 11
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2023 Amount Series B - Gleamer Valuation Supernova Invest , Heal Capital
Sep, 2020 Amount Series A - Gleamer Valuation MACSF , Crista Galli Ventures
Jul, 2019 Amount Grant - Gleamer Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Gleamer

Gleamer has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include RadNet, EIT Health and Bpifrance. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Heal Capital is focused on investing in HealthTech startups.
Founded Year Domain Location
Venture capital fund focused on tech companies
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Gleamer

Gleamer has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Pixyl. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
AI tools for neuroimage analysis are developed for clinicians.
2015
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Gleamer

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Gleamer Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Gleamer

Gleamer operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Perspectum, Qure.ai, IXICO, Zebra Medical Vision and Deeptek, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Precision medicine software for liver disease diagnosis is offered.
domain founded_year HQ Location
AI-powered solutions for medical imaging diagnostics
domain founded_year HQ Location
AI-based medical image management and analysis solutions for healthcare organizations
domain founded_year HQ Location
Provider of AI and SaaS-based medical image based decision support tools
domain founded_year HQ Location
AI-augmented diagnostic tools for radiology imaging are developed.
domain founded_year HQ Location
AI-driven solutions for medical diagnostic imaging are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Gleamer

Frequently Asked Questions about Gleamer

When was Gleamer founded?

Gleamer was founded in 2017 and raised its 1st funding round 1 year after it was founded.

Where is Gleamer located?

Gleamer is headquartered in Paris, France.

Is Gleamer a funded company?

Gleamer is a funded company, having raised a total of $40.01M across 4 funding rounds to date. The company's 1st funding round was a Grant of $44.8K, raised on Sep 24, 2018.

What does Gleamer do?

Gleamer was founded in 2017 and is based in Paris, France. Operations center on the healthcare technology sector, where an AI-based platform is developed for medical image interpretation. The flagship Gleamer Copilot integrates multiple AI models to support analysis of X-rays, CT scans, and MRIs. Deep learning algorithms are employed to identify anomalies and produce reports, aiding radiologists in diagnostics and clinical processes.

Who are the top competitors of Gleamer?

Gleamer's top competitors include Perspectum, Qure.ai and Deeptek.

What products or services does Gleamer offer?

Gleamer offers BoneView, ChestView, BoneMetrics, BoneAge, and BreastView.

How many acquisitions has Gleamer made?

Gleamer has made 1 acquisition, including Pixyl.

Who are Gleamer's investors?

Gleamer has 12 investors. Key investors include RadNet, EIT Health, Bpifrance, Supernova Invest, and Heal Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available